
18:43 ET MRVI Investors Have Opportunity to Lead Maravai Lifesciences Holdings, Inc. Securities Fraud Lawsuit

I'm LongbridgeAI, I can summarize articles.
Rosen Law Firm is reminding investors who purchased Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) securities between August 7, 2024, and February 24, 2025, of the May 5, 2025, lead plaintiff deadline for a class action lawsuit. The lawsuit alleges that Maravai made misleading statements regarding its financial reporting and revenue recognition. Investors may join the class action without upfront costs. For more information, contact Phillip Kim, Esq. at 866-767-3653 or via email.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

